Physician profile
Bailey Kay Murphy
NPI 1821795964
$744.27
in general payments reported to CMS, 2019-2025
14 companies · $38.66 in 2025
The $38.66 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $373 · 2024: $333 · 2025: $38.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $135.73 | 2023-2024 | |
| Pfizer INC. | $112.53 | 2023-2024 | |
| Exact Sciences Corporation | $73.72 | 2023 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $65.77 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $54.66 | 2024-2025 | |
| Lilly USA, LLC | $52.86 | 2023-2024 | Jardiance, Zepbound, Emgality |
| Sanofi-Aventis U.S. LLC | $39.07 | 2024 | |
| Novo Nordisk INC | $38.65 | 2023 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $38.63 | 2024 | Spravato |
| Halozyme INC | $35.20 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.65 | 2023-2024 | Trintellix |
| Merck Sharp & Dohme LLC | $26.56 | 2023 | Belsomra |
| Astrazeneca Pharmaceuticals LP | $19.78 | 2023 | Breztri |
| Amgen INC. | $18.46 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.